Allentra USA has published new research based on its Q1 2026 US Market Entry Roadshow, drawing on structured assessments of twenty-one UK companies across fourteen sectors.
The report concludes that the most common failure pattern is not a weak product or lack of US demand, but a combination of unresolved commercial model questions and structural gaps that accumulate quietly until they become expensive.
The research is based on a programme of workshops, discovery consultations and health checks conducted with UK growth-stage businesses at different stages of US expansion.
Fourteen of the 21 companies assessed had already entered the US market at the time of review, with US revenue ranging from zero to several million pounds.
For growth-stage businesses in Birmingham and the West Midlands, the findings reinforce that US expansion success depends not just on ambition or product quality, but on the strength of the commercial model, operating structure and execution plan behind it.
To explore the findings in more detail, Allentra USA will be running a briefing event in Birmingham on 14 July for chambers, advisers, membership organisations and other ecosystem partners supporting growth-stage businesses in Birmingham and the West Midlands with US expansion ambitions.
Further information and registration details are available on the website.
The report argues that the US market does not punish companies mainly because the opportunity is absent, but because critical commercial and structural decisions are made too late, in the wrong order, or without understanding how they connect.
Ian Collins (pictured), managing partner of Allentra USA, said: “For most of the companies in this cohort, the US opportunity was real.
“What was missing was the architecture beneath the ambition. The most common pattern was not one dramatic mistake. It was a combination of commercial uncertainty and structural exposure that had not yet been addressed properly.
“The companies that were best prepared for the US were not necessarily the ones with the biggest budgets.
“They were the ones asking better questions earlier — about route to market, pricing, hiring, entity structure, tax exposure, contracts and investor readiness — before those issues became costly to fix.”
The report finds that commercial readiness is often weaker than founders realise. Fifteen of the 21 companies could describe a US revenue aspiration in reasonable detail, but fewer than half had a considered position on how that revenue would actually be generated, through which channels, by whom, and at what cost of acquisition.
At the same time, the structural picture was often underdeveloped even among companies already trading in the market.
Of the 14 businesses already generating US revenue, only four had a functioning US entity. More than 80 per cent of those already generating US revenue had triggered state sales tax obligations they had not addressed.
The report also highlights an “investment gap nobody plans for”, warning that unresolved compliance and structural issues can become a negotiating lever in fundraising.
A company with genuine US traction but unaddressed nexus liabilities, weak entity structure or undocumented transfer pricing may not simply present risk to investors — it may weaken its own negotiating position.
